FI970765A - Dinukleotidi- ja oligonukleotidianalogien välituotteet - Google Patents

Dinukleotidi- ja oligonukleotidianalogien välituotteet Download PDF

Info

Publication number
FI970765A
FI970765A FI970765A FI970765A FI970765A FI 970765 A FI970765 A FI 970765A FI 970765 A FI970765 A FI 970765A FI 970765 A FI970765 A FI 970765A FI 970765 A FI970765 A FI 970765A
Authority
FI
Finland
Prior art keywords
dinucleotide
intermediates
oligonucleotide analogs
oligonucleotide
analogs
Prior art date
Application number
FI970765A
Other languages
English (en)
Swedish (sv)
Other versions
FI970765A0 (fi
Inventor
Anthony David Baxter
Roger John Taylor
Stephen Paul Collingwood
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI970765A0 publication Critical patent/FI970765A0/fi
Publication of FI970765A publication Critical patent/FI970765A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04Cyclic acetals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI970765A 1994-09-03 1997-02-24 Dinukleotidi- ja oligonukleotidianalogien välituotteet FI970765A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9417746A GB9417746D0 (en) 1994-09-03 1994-09-03 Chemical compounds
PCT/GB1995/001955 WO1996008503A1 (en) 1994-09-03 1995-08-17 Intermediates for dinucleotide and oligonucleotide analogues

Publications (2)

Publication Number Publication Date
FI970765A0 FI970765A0 (fi) 1997-02-24
FI970765A true FI970765A (fi) 1997-04-25

Family

ID=10760791

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970765A FI970765A (fi) 1994-09-03 1997-02-24 Dinukleotidi- ja oligonukleotidianalogien välituotteet

Country Status (10)

Country Link
US (1) US5952478A (fi)
EP (1) EP0778843A1 (fi)
JP (1) JPH10506621A (fi)
AU (1) AU695607B2 (fi)
CA (1) CA2198900A1 (fi)
FI (1) FI970765A (fi)
GB (1) GB9417746D0 (fi)
HU (1) HUT76857A (fi)
NO (1) NO970870L (fi)
WO (1) WO1996008503A1 (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5879700A (en) * 1991-10-15 1999-03-09 Hostetler; Karl Y. Nucleoside analogue phosphates for topical use
US6639061B1 (en) 1999-07-07 2003-10-28 Isis Pharmaceuticals, Inc. C3′-methylene hydrogen phosphonate oligomers and related compounds
GB9604669D0 (en) 1996-03-05 1996-05-01 Ciba Geigy Ag Chemical compounds
GB9612600D0 (en) 1996-06-13 1996-08-21 Ciba Geigy Ag Chemical compounds
US6414135B1 (en) 1999-07-07 2002-07-02 Isis Pharmaceuticals, Inc. C3′-methylene hydrogen phosphonate monomers and related compounds
US8324179B2 (en) * 2007-02-09 2012-12-04 Gilead Sciences, Inc. Nucleoside analogs for antiviral treatment
CN103209987B (zh) 2010-09-22 2017-06-06 艾丽奥斯生物制药有限公司 取代的核苷酸类似物
AU2012358804B2 (en) 2011-12-22 2018-04-19 Alios Biopharma, Inc. Substituted phosphorothioate nucleotide analogs
WO2013142124A1 (en) 2012-03-21 2013-09-26 Vertex Pharmaceuticals Incorporated Solid forms of a thiophosphoramidate nucleotide prodrug
EP2827876A4 (en) 2012-03-22 2015-10-28 Alios Biopharma Inc PHARMACEUTICAL COMBINATIONS WITH A THIONUCLEOTIDE ANALOG

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3307744A1 (de) * 1983-03-04 1984-09-06 Gesellschaft für Biotechnologische Forschung mbH (GBF), 3300 Braunschweig 2'-desoxy-3'-phosphonylmethyl-nucleoside
DE4037363A1 (de) * 1990-04-09 1991-10-10 Europ Lab Molekularbiolog 2-0-alkylnukleotide sowie polymere, die solche nukleotide enthalten
US5378825A (en) * 1990-07-27 1995-01-03 Isis Pharmaceuticals, Inc. Backbone modified oligonucleotide analogs
GB9304618D0 (en) * 1993-03-06 1993-04-21 Ciba Geigy Ag Chemical compounds
GB9311682D0 (en) * 1993-06-05 1993-07-21 Ciba Geigy Ag Chemical compounds

Also Published As

Publication number Publication date
AU695607B2 (en) 1998-08-20
GB9417746D0 (en) 1994-10-19
US5952478A (en) 1999-09-14
NO970870L (no) 1997-04-17
EP0778843A1 (en) 1997-06-18
WO1996008503A1 (en) 1996-03-21
FI970765A0 (fi) 1997-02-24
HUT76857A (en) 1997-12-29
JPH10506621A (ja) 1998-06-30
AU3229695A (en) 1996-03-29
CA2198900A1 (en) 1996-03-21
NO970870D0 (no) 1997-02-26

Similar Documents

Publication Publication Date Title
EE9600097A (et) Geenitranskriptide võrdlev analüüs
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
BR9408491A (pt) Utilização de carbono descartado
DE69608448D1 (de) Reduktion des biobewuchses
ZA943892B (en) Dinucleotide analogues intermediates therefor and oligonucleotides derived therefrom
ID18679A (id) Penggunaan terapi lanjutan
BR1100839A (pt) Gene homebox de interrupção de crescimento
DE69518743D1 (de) Modifizierung von nukleotidanalogen
GB9610830D0 (en) Use of hollow microcapsules
FI965204A0 (fi) Bromelaiinin lääkekäyttö
FI970765A (fi) Dinukleotidi- ja oligonukleotidianalogien välituotteet
TR199701051A3 (tr) 2' -Fluoro-5-metil- -l-arabino-furanosilüridin hazirlanma prosesi
ID24270A (id) Penghilang sumbatan keratotik
FI963263A0 (fi) Bromelaiinin lääkinnällinen käyttö
DE69614371D1 (de) Fluorierte gangliosid-gm3-analoge und ihre zwischenprodukte
FI951212A (fi) beta-metyylikarbapeneemivälituotteiden valmistus
FI971378A (fi) Menetelmiä ja välituotteita 3-aminobentso(b)-atsepinonien valmistusta varten
GB9720087D0 (en) Preparation of cyclopropylethyne and intermediates for preparation of cyclopropylethyne
ZA959905B (en) 2-[4-Biphenyloxymethylene]anilides preparation thereof and intermediates therefor and use thereof
ID18842A (id) Mekanisme pembangkitan gaya peredam
ID24344A (id) Pemurnian propilena oksida
ID17328A (id) Pemurnian epsilon-kaprolaktam
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
KR950024188U (ko) 갈치주낚용 도래의 고정구
KR960013386U (ko) 착탈식 지압 링